- Home
- AVTX vs FCO Comparison
AVTX vs FCO Comparison
Compare AVTX & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- FCO
- Stock Information
- Founded
- AVTX 2011
- FCO 1991
- Country
- AVTX United States
- FCO United Kingdom
- Employees
- AVTX N/A
- FCO N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- AVTX Health Care
- FCO Finance
- Exchange
- AVTX Nasdaq
- FCO Nasdaq
- Market Cap
- AVTX 57.4M
- FCO 85.6M
- IPO Year
- AVTX 2015
- FCO N/A
- Fundamental
- Price
- AVTX $4.88
- FCO $6.45
- Analyst Decision
- AVTX Strong Buy
- FCO
- Analyst Count
- AVTX 7
- FCO 0
- Target Price
- AVTX $31.00
- FCO N/A
- AVG Volume (30 Days)
- AVTX 97.2K
- FCO 100.1K
- Earning Date
- AVTX 08-11-2025
- FCO 01-01-0001
- Dividend Yield
- AVTX N/A
- FCO 14.96%
- EPS Growth
- AVTX N/A
- FCO N/A
- EPS
- AVTX N/A
- FCO 0.43
- Revenue
- AVTX $441,000.00
- FCO N/A
- Revenue This Year
- AVTX N/A
- FCO N/A
- Revenue Next Year
- AVTX N/A
- FCO N/A
- P/E Ratio
- AVTX N/A
- FCO $12.30
- Revenue Growth
- AVTX N/A
- FCO N/A
- 52 Week Low
- AVTX $3.39
- FCO $4.73
- 52 Week High
- AVTX $16.00
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- AVTX 54.21
- FCO 64.78
- Support Level
- AVTX $4.50
- FCO $6.16
- Resistance Level
- AVTX $5.00
- FCO $6.41
- Average True Range (ATR)
- AVTX 0.32
- FCO 0.09
- MACD
- AVTX 0.03
- FCO 0.00
- Stochastic Oscillator
- AVTX 62.50
- FCO 100.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.